Moderna, Inc.'s diluted shares was 389M shares for fiscal year 2025 (the twelve months to 31 Dec 2025), up 1.3% from fiscal 2024.
In the third quarter of fiscal 2026 (the three months to 30 Sep 2026) it was 430M shares, up 10.3% from a year earlier.
From Moderna, Inc.'s annual and quarterly reports, compiled and checked by AapWire. Latest report filed 6 Nov 2026.
Fiscal 2025
389M
+1.3%
Q3 FY2026
430M
+10.3% on a year
Growth over 9 years
+22.9%
a year, FY 2016–FY 2025
Diluted shares by fiscal year
Change on the year before, under each year. From FY 2016 to FY 2025, Moderna, Inc.'s diluted shares went from 60.7M shares to 389M shares, a compound annual change of +22.9%; the highest was 431M shares in FY 2021.
Moderna, Inc. diluted shares, fiscal years
Period
FY 2016
FY 2017
FY 2018
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
Diluted shares
60.7M
64.5M
81.1M
331M
381M
431M
416M
382M
384M
389M
Period end
31 Dec 2016
31 Dec 2017
31 Dec 2018
31 Dec 2019
31 Dec 2020
31 Dec 2021
31 Dec 2022
31 Dec 2023
31 Dec 2024
31 Dec 2025
Diluted shares by quarter
The last eight fiscal quarters. Each is compared with the same quarter a year earlier on the company's page.
Moderna, Inc. diluted shares, fiscal quarters
Period
Q4 FY2024
Q1 FY2025
Q2 FY2025
Q3 FY2025
Q4 FY2025
Q1 FY2026
Q2 FY2026
Q3 FY2026
Diluted shares
386M
386M
388M
390M
392M
395M
398M
430M
Period end
31 Dec 2024
31 Mar 2025
30 Jun 2025
30 Sep 2025
31 Dec 2025
31 Mar 2026
30 Jun 2026
30 Sep 2026
How diluted shares is measured
Diluted shares is the weighted average number of shares outstanding in the period, counting the shares that options, warrants and convertible securities could add; it is the count earnings per share is divided by. Figures are read from the report the company filed and checked against accounting identities; one that does not pass is left blank rather than estimated. See data and methodology.
Moderna, Inc.'s other figures
Diluted shares of comparable companies
Everything on MRNA, in the terminal.
Twenty years of history, operating KPIs and segments, guidance against results, valuation, insiders and holders, charts and alerts.